Functional immunoassays using an in-vitro malaria liver-stage infection model: where do we go from here?
For more than 25 years, the ISI assay and ILSDA have been used to study the development of the malaria parasite in the liver, to discover and characterize sporozoite and liver-stage antigens, to support the development of malaria vaccine candidates, and to search for immunological correlates of protection in animals and in humans. Although both assays have been limited by low sporozoite invasion rates, significant biological variability, and the subjective nature of manually counting hepatocytes containing parasites as the read-out, they have nevertheless been useful tools for exploring parasite biology. This review describes the origin, application and current status of these assays, critically discusses the need for improvements, and explores the roles of these assays in supporting the development of an effective vaccine against Plasmodium falciparum malaria.
House
Brent L
BL
US Military Malaria Vaccine Program, Naval Medical Research Center/Walter Reed Army Institute of Research, Silver Spring, MD 21737, USA.
Hollingdale
Michael R
MR
Sacci
John B
JB
Richie
Thomas L
TL
D006801:Humans; D007118:Immunoassay / Q000379:methods*; D008099:Liver / Q000469:parasitology*; D016778:Malaria, Falciparum / Q000175:diagnosis* / Q000469:parasitology; D010963:Plasmodium falciparum / Q000302:isolation & purification*; D034101:Sporozoites / Q000254:growth & development